Clinical trial NCT04130243 - References

Pulmonary Arterial Hypertension — Biomarkers in Pediatric Congenital Heart Disease and PAH

Citation(s)

•   Baum H, Hinze A, Bartels P, Neumeier D
  Reference values for cardiac troponins T and I in healthy neonates. Clin Biochem. 2004 Dec;37(12):1079-82.
•   Beghetti M, Berger RM, Schulze-Neick I, Day RW, Pulido T, Feinstein J, Barst RJ, Humpl T; TOPP Registry Investigators
  Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice. Eur Respir J. 2013 Sep;42(3):689-700. doi: 10.1183/09031936.00140112. Epub 2013 Apr 5.
•   Borgdorff MA, Koop AM, Bloks VW, Dickinson MG, Steendijk P, Sillje HH, van Wiechen MP, Berger RM, Bartelds B
  Clinical symptoms of right ventricular failure in experimental chronic pressure load are associated with progressive diastolic dysfunction. J Mol Cell Cardiol. 2015 Feb;79:244-53. doi: 10.1016/j.yjmcc.2014.11.024. Epub 2014 Dec 5.
•   Braunwald E
  Biomarkers in heart failure. N Engl J Med. 2008 May 15;358(20):2148-59. doi: 10.1056/NEJMra0800239. Review.
•   Calvier L, Legchenko E, Grimm L, Sallmon H, Hatch A, Plouffe BD, Schroeder C, Bauersachs J, Murthy SK, Hansmann G
  Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension. Heart. 2016 Mar;102(5):390-6. doi: 10.1136/heartjnl-2015-308365.
•   de Boer RA, Daniels LB, Maisel AS, Januzzi JL Jr
  State of the Art: Newer biomarkers in heart failure. Eur J Heart Fail. 2015 Jun;17(6):559-69. doi: 10.1002/ejhf.273. Epub 2015 Apr 16. Review.
•   Fernandes BA, Maher KO, Deshpande SR
  Cardiac biomarkers in pediatric heart disease: A state of art review. World J Cardiol. 2016 Dec 26;8(12):719-727. doi: 10.4330/wjc.v8.i12.719. Review.
•   Hartupee J, Mann DL
  Positioning of inflammatory biomarkers in the heart failure landscape. J Cardiovasc Transl Res. 2013 Aug;6(4):485-92. doi: 10.1007/s12265-013-9467-y. Epub 2013 May 11. Review.
•   Kato TS, Armstrong HF, Schulze PC, Lippel M, Amano A, Farr M, Bacchetta M, Bartels MN, Di Tullio MR, Homma S, Mancini D
  Left and Right Ventricular Functional Dynamics Determined by Echocardiograms Before and After Lung Transplantation. Am J Cardiol. 2015 Aug 15;116(4):652-9. doi: 10.1016/j.amjcard.2015.05.027. Epub 2015 May 21.
•   Knofczynski GT, Mundfrom D
  Sample sizes when using multiple linear regression for prediction. Educational and Psychological Measurement. 2008 June; 68(3):431-442.
•   Koch A, Zink S, Singer H
  B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J. 2006 Apr;27(7):861-6. Epub 2006 Feb 8.
•   Leberkühne LJ, Ploegstra MJ, Douwes JM, Bartelds B, Roofthooft MT, Hillege HL, Berger RM
  Serially Measured Uric Acid Levels Predict Disease Severity and Outcome in Pediatric Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2017 Feb 1;195(3):401-404. doi: 10.1164/rccm.201606-1152LE.
•   Nagarajan V, Hernandez AV, Tang WH
  Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart. 2012 Dec;98(24):1778-86. doi: 10.1136/heartjnl-2012-301779. Epub 2012 Oct 31. Review.
•   Norozi K, Zoege M, Buchhorn R, Wessel A, Geyer S
  The influence of congenital heart disease on psychological conditions in adolescents and adults after corrective surgery. Congenit Heart Dis. 2006 Nov;1(6):282-8. doi: 10.1111/j.1747-0803.2006.00048.x.
•   Pang PS, Xue Y, Defilippi C, Silver M, Januzzi J, Maisel A
  The role of natriuretic peptides: from the emergency department throughout hospitalization. Congest Heart Fail. 2012 Sep-Oct;18 Suppl 1:S5-8. doi: 10.1111/j.1751-7133.2012.00307.x. Review.
•   Pintalhao M, Castro-Chaves P, Vasques-Novoa F, Gonçalves F, Mendonça L, Fontes-Carvalho R, Lourenço P, Almeida P, Leite-Moreira A, Bettencourt P
  Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload. Eur J Heart Fail. 2017 Feb;19(2):218-225. doi: 10.1002/ejhf.611. Epub 2016 Aug 4.
•   Ploegstra MJ, Douwes JM, Roofthooft MT, Zijlstra WM, Hillege HL, Berger RM
  Identification of treatment goals in paediatric pulmonary arterial hypertension. Eur Respir J. 2014 Dec;44(6):1616-26. doi: 10.1183/09031936.00030414. Epub 2014 Jul 17.
•   Reddy S, Bernstein D
  Molecular Mechanisms of Right Ventricular Failure. Circulation. 2015 Nov 3;132(18):1734-42. doi: 10.1161/CIRCULATIONAHA.114.012975. Review.
•   Takatsuki S, Wagner BD, Ivy DD
  B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension. Congenit Heart Dis. 2012 May-Jun;7(3):259-67. doi: 10.1111/j.1747-0803.2011.00620.x. Epub 2012 Feb 10.
•   Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N
  Universal definition of myocardial infarction. Circulation. 2007 Nov 27;116(22):2634-53. Epub 2007 Oct 19.
•   Torbicki A, Kurzyna M, Kuca P, Fijalkowska A, Sikora J, Florczyk M, Pruszczyk P, Burakowski J, Wawrzynska L
  Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation. 2003 Aug 19;108(7):844-8. Epub 2003 Aug 4.
•   Van Albada ME, Loot FG, Fokkema R, Roofthooft MT, Berger RM
  Biological serum markers in the management of pediatric pulmonary arterial hypertension. Pediatr Res. 2008 Mar;63(3):321-7. doi: 10.1203/PDR.0b013e318163a2e7.
•   van Loon RL, Roofthooft MT, Delhaas T, van Osch-Gevers M, ten Harkel AD, Strengers JL, Backx A, Hillege HL, Berger RM
  Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies. Am J Cardiol. 2010 Jul 1;106(1):117-24. doi: 10.1016/j.amjcard.2010.02.023.
•   Webb GD
  Challenges in the care of adult patients with congenital heart defects. Heart. 2003 Apr;89(4):465-9. Review.
•   Zelniker T, Uhlmann L, Spaich S, Friedrich J, Preusch MR, Meyer FJ, Katus HA, Giannitsis E
  Novel biomarkers for risk stratification in pulmonary arterial hypertension. ERJ Open Res. 2015 Oct 19;1(2). pii: 00008-2015. eCollection 2015 Oct.

Biomarkers in Congenital Heart Diseases and Pulmonary Arterial Hypertension

Details for clinical trial NCT04130243